| Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction TS Baker, WW Newcomb, NH Olson, LM Cowsert, C Olson, JC Brown Biophysical journal 60 (6), 1445-1456, 1991 | 575 | 1991 |
| Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation L Cowsert, B Baker, J McNeil, S Freier, H Sasmor, D Brooks, C Ohashi, ... US Patent App. 10/388,263, 2003 | 495 | 2003 |
| Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth J Chen, W Wu, SK Tahir, PE Kroeger, SH Rosenberg, LM Cowsert, ... Neoplasia 2 (3), 235-241, 2000 | 326 | 2000 |
| 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells V Taylor, M Wong, C Brandts, L Reilly, NM Dean, LM Cowsert, S Moodie, ... Molecular and cellular biology, 2000 | 240 | 2000 |
| Antisense oligonucleotide inhibition of papillomavirus ST Crooke, CK Mirabelli, DJ Ecker, LM Cowsert US Patent 5,457,189, 1995 | 207 | 1995 |
| System of components for preparing oligonucleotides LM Cowsert, BF Baker, J McNeil, SM Freier, HM Sasmor, DG Brooks, ... US Patent 7,321,828, 2008 | 195 | 2008 |
| Antisense modulation of CD40 expression CF Bennett, LM Cowsert, AM Siwkowski US Patent 7,745,609, 2010 | 181 | 2010 |
| Antisense modulation of caspase 3 expression H Zhang, LM Cowsert US Patent 6,303,374, 2001 | 176 | 2001 |
| Cholic acid-oligonucleotide conjugates for antisense applications M Manoharan, LK Johnson, CF Bennett, TA Vickers, DJ Ecker, ... Bioorganic & Medicinal Chemistry Letters 4 (8), 1053-1060, 1994 | 157 | 1994 |
| Antisense inhibiton of human G-alpha-12 expression LM Cowsert US Patent 5,998,206, 1999 | 152 | 1999 |
| Antisense modulation of calreticulin expression CF Bennett, LM Cowsert US Patent 6,426,220, 2002 | 139 | 2002 |
| Antisense modulation of AKT-1 expression BP Monia, LM Cowsert US Patent 5,958,773, 1999 | 131 | 1999 |
| Chemical modifications to improve uptake and bioavailability of antisense oligonucleotides M Manoharan, LK Johnson, DPC McGee, CJ Guinosso, K Ramasamy, ... Annals of the New York Academy of Sciences 660 (1), 306-309, 1992 | 125 | 1992 |
| Antisense inhibition of PI3K p85 expression BP Monia, LM Cowsert US Patent 6,100,090, 2000 | 122 | 2000 |
| Inhibition of influenza viruses by antisense oligonucleotides LM Cowsert, DJ Ecker US Patent 5,580,767, 1996 | 122 | 1996 |
| In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts LM Cowsert, MC Fox, G Zon, CK Mirabelli Antimicrobial agents and chemotherapy 37 (2), 171-177, 1993 | 120 | 1993 |
| Antisense inhibition of MAP kinase kinase 6 expression BP Monia, LM Cowsert US Patent 6,033,910, 2000 | 117 | 2000 |
| Antisense inhibition of interleukin-15 expression CF Bennett, LM Cowsert US Patent 5,985,663, 1999 | 115 | 1999 |
| Antisense oligonucleotides as a tool for gene functionalization and target validation CF Bennett, LM Cowsert Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1489 (1 …, 1999 | 114 | 1999 |
| Antisense modulation of sterol regulatory element-binding protein-1 expression C Bennett, S Freier, N Dean, B Monia, W Gaarde, J Karras, H Zhang, ... US Patent App. 11/014,360, 2005 | 109 | 2005 |
